micro News and Research

RSS

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

A new study evaluated the impact of the lower SARS-CoV-2 vaccine dosages in younger populations.

18 Jul 2022

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs).

18 Jul 2022

Scientists evaluate immunostimulatory glycolipid against SARS-CoV-2 infection

A new study showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including SARS-CoV-2, in vivo.

18 Jul 2022

Novel nanoligomer approach to treat severe COVID-19

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

17 Jul 2022

Scientists combine robotics with biology to construct biohybrid microrobots

A team of scientists in the Physical Intelligence Department at the Max Planck Institute for Intelligent Systems have combined robotics with biology by equipping E. coli bacteria with artificial components to construct biohybrid microrobots.

15 Jul 2022

Mustard seed extract suppresses hydrogen peroxide levels in juice products

Researchers hypothesize that proteins with low nutritional value could be effectively used for antioxidant stabilization in orange juice.

13 Jul 2022

Fortified breastmilk does not influence IQ in preterm infants

Scientists compare the cognitive and psychological development of preterm infants who were breastfed with or without fortification.

13 Jul 2022

Researchers use lasers to turn white blood cells into medicinal microrobots

Medicinal microrobots could help physicians better treat and prevent diseases. But most of these devices are made with synthetic materials that trigger immune responses in vivo.

13 Jul 2022

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

A new study reports the production of neutralizing antibodies against SARS-CoV-2 in hyperimmunized hens.

12 Jul 2022

Clinical presentation of monkeypox infection in two Israeli males

Researchers described the symptomatology and clinical manifestations of monkeypox infections among two Israeli patients.

12 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Study sheds light on cell type-specific biomarkers of melanoma

A new UC Davis-led study sheds light on cell type-specific biomarkers, or signs, of melanoma. The research was recently published in the Journal of Investigative Dermatology.

10 Jul 2022

Discovery of multiple new SARS-CoV-2 MPro inhibitors

In a recent study posted to the bioRxiv* preprint server, researchers performed an extensive library docking for new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) covalent and non-covalent inhibitors.

8 Jul 2022

Novel point-of-care biosensing device detects measles virions in human saliva

Measles is one of the most infectious airborne viruses worldwide. An inexpensive and effective vaccine is available, but Measles is common in developing countries and sporadic outbreaks also occur in developed countries, primarily due to non-vaccinated people.

7 Jul 2022

Scientists unravel the neuronal metabolism in learning and memory

Exploring the predictive properties of neuronal metabolism can contribute to our understanding of how humans learn and remember.

5 Jul 2022

Redlined neighborhoods in the 1930s now suffer from higher rates of poor health outcomes

A new study from University Hospitals (UH) Harrington Heart & Vascular Institute further proves that people living in areas that were subjected to housing discrimination decades ago now suffer from higher rates of poor health outcomes, including heart disease, kidney failure and diabetes.

5 Jul 2022

Novel oral nano-in-micro system provides efficient curcumin delivery to alleviate ulcerative colitis

A new study showed that the newly designed oral nano-in-micro hydrogel delivery platform could be efficiently used to deliver curcumin for the treatment of Ulcerative Colitis.

5 Jul 2022

The influence of immunosuppressive therapy on the development of adaptive immunity after SARS-CoV-2 vaccination

Researchers evaluated the impact of immunosuppressive therapies on the induction of adaptive immunity after COVID-19 vaccination.

5 Jul 2022

Discussing tools and resources to support the bladder cancer patient community

In this interview, Dr. Ignacio Durán and Alex Filicevas discuss key challenges and opportunities in the bladder cancer disease landscape and the future of care. This episode focuses on the bladder cancer patient support landscape, including a review of the tools and resources available to the community, as well as key unmet needs to address.

From Janssen Pharmaceuticals 4 Jul 2022